WisdomTree Prices Offering of $25.0 Million of 4.25% Convertible Senior Notes
NEW YORK, Aug. 11, 2020 (GLOBE NEWSWIRE) — WisdomTree Investments, Inc. (NASDAQ: WETF) (“WisdomTree”) today announced the pricing of an […]
Applied Optoelectronics Announces Record Laser Production
SUGAR LAND, Texas, Aug. 11, 2020 (GLOBE NEWSWIRE) — Applied Optoelectronics, Inc. (NASDAQ: AAOI), a leading provider of fiber-optic access […]
Fulcrum Therapeutics Reports Recent Business Highlights and Second Quarter 2020 Financial Results
– Conference call scheduled for 8:00 a.m. ET today –CAMBRIDGE, Mass., Aug. 11, 2020 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc. (Nasdaq: […]
Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
Merger between Chondrial Therapeutics and Zafgen completed and company began operating as Larimar TherapeuticsPhase 1 clinical trial of CTI-1601 for […]
FirstCash Announces Commencement of Offering of Senior Notes
FORT WORTH, Texas , Aug. 11, 2020 (GLOBE NEWSWIRE) — FirstCash, Inc. (the “Company”) (Nasdaq: FCFS) today announced that it […]
aTyr Pharma Announces Partner Kyorin Pharmaceutical, Co., Ltd. Proceeds to Phase 1 Trial of ATYR1923 in Japan
SAN DIEGO, Aug. 11, 2020 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery […]
Aemetis Launches Aemetis Health Products Subsidiary
Company to offer Blended Liquid and Gel Hand Sanitizer as Bulk and Packaged ProductsCUPERTINO, CA, Aug. 11, 2020 (GLOBE NEWSWIRE) […]
Glory Star New Media Group Holdings Limited Releases Letter to Shareholders on Progress to Date and Future Growth Strategies
Beijing, Aug. 11, 2020 (GLOBE NEWSWIRE) — Glory Star New Media Group Holdings Limited (NASDAQ: GSMG, GSMGW) (“Glory Star” or […]
Latest Release of Altair® PBS Professional® Offers Up to Tenfold Faster Performance for More Diverse and Dynamic HPC Workloads
TROY, Mich., Aug. 11, 2020 (GLOBE NEWSWIRE) — Altair (Nasdaq: ALTR), a global technology company providing solutions in product development, […]
FibroGen Announces First Patient Enrolled in Pamrevlumab Phase 3 Clinical Trial in Patients with Duchenne Muscular Dystrophy
SAN FRANCISCO, Aug. 11, 2020 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) announced the initiation of LELANTOS, a Phase 3, […]
